✦ LIBER ✦

Frequency of BRCA1 and BRCA2 mutations in a clinic-based series of breast and ovarian cancer families

✍ Scribed by Susan A.J. Vaziri; Lisa M. Krumroy; Majid Rostai; Graham Casey

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 29 KB
Volume: 17
Category: Article
ISSN: 1059-7794
DOI: 10.1002/1098-1004(2001)17:1<74::aid-humu13>3.0.co;2-i

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Frequency of BRCA1 and BRCA2 germline mu

Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families

✍ Noriko Ikeda; Yasuo Miyoshi; Kohri Yoneda; Eiichi Shiba; Yoshizo Sekihara; Morit 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 71 KB 👁 1 views

High frequency of recurrent mutations in

High frequency of recurrent mutations in BRCA1 and BRCA2 genes in Polish families with breast and ovarian cancer

✍ Ewa Grzybowska; Helena Zientek; Anna Jasinska; Marek Rusin; Piotr Kozlowski; Krz 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 347 KB 👁 1 views

BRCA1-related breast cancer in Austrian

✍ Teresa M. U. Wagner; Regine A. Möslinger; Daniela Muhr; Gudrun Langbauer; Kora H 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 76 KB 👁 1 views

We identified 17 BRCA1 mutations in 86 Austrian breast and ovarian cancer families (20%) that were screened for mutations by denaturing high-performance liquid chromatography (DHPLC) and the protein truncation test (PTT). Eleven distinct mutations were detected, 4 of them (962del4, 2795del4, 3135del

Clinical management of BRCA1- and BRCA2-

Clinical management of BRCA1- and BRCA2-associated breast cancer

✍ Stephen E. Karp 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 1 views

The recent discovery of the breast cancer-associated genes BRCA1 and BRCA2 has changed the clinical care provided to women at high risk of breast cancer. We will review what is currently known about the clinical management of patients who bear (or are suspected of bearing) mutations in either of the

Increased frequency of TP53 mutations in

Increased frequency of TP53 mutations in BRCA1 and BRCA2 ovarian tumours

✍ Susan J. Ramus; Lynda G. Bobrow; Paul D.P. Pharoah; Damon S. Finnigan; Ami Fishm 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 1 views

We screened 81 ovarian tumours (30 BRCA1 associated, 18 BRCA2 associated, and 33 sporadic) for somatic TP53 mutations using both DNA analysis and immunostaining. TP53 mutations were significantly more frequent in tumours with mutations in BRCA1 (70% by immunostaining and 60% by DNA analysis) and BRC

Prevalence of founder BRCA1 and BRCA2 mu

Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in hungary

✍ Marco Van der Looij; Csilla Szabo; Istvan Besznyak; Gyorgy Liszka; Bela Csokay; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 55 KB 👁 2 views

We have investigated the impact of BRACA1 and BRACA2 mutations that were frequently identified among Hungarian high-risk breast-ovarian cancer families (Ramus et al., 1997b, AJHG), on the development of breast and ovarian cancer in the general Hungarian population. The prevalence of 3 BRCA1 mutation